-- 傑富瑞(Jefferies)週五發布的一份報告稱，麥格理集團(ASX:MQG) 2026財年的業績超出預期，主要得益於成本降低和平均稅率下降。 該公司業績表現“非常強勁”，稅後淨利潤達48.5億澳元，年增30%，超出傑富瑞9%的預期。這家股票研究公司表示，營收中「大幅」提列了撥備，掩蓋了實際業績的強勁成長。 這項展望與傑富瑞先前對麥格理集團2027財年稅後淨利潤約50億澳元的預期相符。 傑富瑞重申對麥格理集團的「買進」評級，目標價為247.40澳元。 麥格理集團股價在周五的交易中下跌1%，此前曾創下歷史新高。
Related Articles
Asia
Regis Resources Says Morgan Stanley, Units Acquire 5.87% Stake
Regis Resources (ASX:RRL) said Morgan Stanley and its subsidiaries became a substantial holder of the firm after acquiring 44.4 million shares, or a 5.87% stake, on Tuesday, according to a Friday Australian bourse filing.
$ASX:RRL
Asia
Jumpcan Pharma's Jianwei Xiaoshi Oral Liquid Added to China's Centralized Procurement Program
Hubei Jumpcan Pharmaceutical's (SHA:600566) Jianwei Xiaoshi Oral Liquid was selected for the National Chinese Patent Medicine's centralized procurement, according to a Friday disclosure to the Shanghai bourse.The drug is used to treat food stagnation and indigestion.During the procurement period, medical institutions will prioritize the use of the selected products, the pharmaceutical company said.
$SHA:600566
Asia
Tabcorp Likely Faces Remediation Costs from Austrac Probe, But Sell-Off Overdone, Jarden Says
Tabcorp Holdings (ASX:TAH) likely faces remediation costs in a new regulatory enforcement investigation, and repeat offender status is also a risk, but neither of those factors justifies the magnitude of the sell-off in the company's stock, Jarden said in a Thursday note.The Australian Transaction Reports and Analysis Center (AUSTRAC) is investigating the company's compliance with anti-money laundering and counter-terrorism financing obligations, citing concerns about its ability to identify and mitigate risks.Jarden noted there is no certainty of a financial penalty as the regulator's disclosure stated that all outcomes are on the table, while previous cases show that a zero-penalty result is possible when the regulator is satisfied with cooperation.AUSTRAC's previous gambling sector penalties have ranged from zero to AU$450 million, the equity research firm said, adding that it views top-line implications for Tabcorp as limited.The company's shares fell sharply after the disclosure of the probe, and at those levels, "the stock appears to be factoring a cost impost well in excess of what the precedent set supports," Jarden said.It maintained an overweight rating on Tabcorp with a target price of AU$1.05, saying it will revisit those assessments if Austrac files civil penalty proceedings or Tabcorp takes on provisions related to the case.The company's shares fell 13% in recent Friday trade.
$ASX:TAH